Corporate News 05-Aug-22
Jagsonpal Pharmaceuticals announces board meeting date
On 9 August 2022
Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 August 2022.
Previous News
Jagsonpal Pharmaceuticals standalone net profit rises 707.83% in the December 2024 quarter
( Results - Announcements 23-Jan-25 07:31 )
Jagsonpal Pharmaceuticals standalone net profit rises 58.69% in the September 2022 quarter
( Results - Announcements 10-Nov-22 08:01 )
Jagsonpal Pharmaceuticals completes acquisition of India and Bhutan biz of Yash Pharma
( Corporate News - 31-May-24 14:15 )
Board of Jagsonpal Pharmaceuticals recommends final dividend
( Corporate News - 07-May-25 09:28 )
Jagsonpal Pharmaceuticals grants 10.47 lakh stock options
( Corporate News - 19-Sep-22 09:07 )
Jagsonpal Pharmaceuticals to convene board meeting
( Corporate News - 04-May-22 12:20 )
Jagsonpal Pharmaceuticals reports standalone net profit of Rs 1.74 crore in the December 2018 quarter
( Results - Announcements 16-Feb-19 09:16 )
Jagsonpal Pharmaceuticals standalone net profit rises 31.03% in the December 2019 quarter
( Results - Announcements 14-Feb-20 12:49 )
Board of Jagsonpal Pharmaceuticals recommends final dividend
( Corporate News - 30-Jul-20 11:00 )
Jagsonpal Pharmaceuticals standalone net profit rises 36.17% in the June 2016 quarter
( Results - Announcements 12-Aug-16 16:54 )
Jagsonpal Pharmaceuticals appoints company secretary
( Corporate News - 11-Oct-19 15:42 )
Other Stories
FAST India partners with Indegene to accelerate biotech innovation in India
03-Jul-25 11:01
LMW schedules board meeting
03-Jul-25 09:15
Julien Agro Infratech announces board meeting date
03-Jul-25 09:15
Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
03-Jul-25 09:15
Shriram Asset Mgt. Company schedules AGM
03-Jul-25 09:14
Ideaforge Technology to convene AGM
03-Jul-25 09:14
D-Link (India) to announce Quarterly Result
03-Jul-25 09:14
Tuni Textile Mills to conduct board meeting
03-Jul-25 09:14
Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
03-Jul-25 09:12
Shakti Pumps launches QIP issue
03-Jul-25 09:08
Back
Top
